BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 31054998)

  • 1. Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice.
    Lo HY; Li CC; Cheng HM; Liu IC; Ho TY; Hsiang CY
    Food Chem Toxicol; 2019 Jul; 129():365-375. PubMed ID: 31054998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosmarinic acid ameliorated psoriatic skin inflammation in mice through the novel inhibition of the interleukin-17A/interleukin-17A receptor interaction.
    Ho TY; Lo HY; Liu IC; Huang SL; Hsiang CY
    Food Funct; 2022 Jun; 13(12):6802-6812. PubMed ID: 35674182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
    El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
    J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.
    Srikanth M; Rasool M
    Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
    Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
    Front Immunol; 2021; 12():635076. PubMed ID: 34025642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
    Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
    Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
    Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
    Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Administration of Vanillin Improves Imiquimod-Induced Psoriatic Skin Inflammation in Mice.
    Cheng HM; Chen FY; Li CC; Lo HY; Liao YF; Ho TY; Hsiang CY
    J Agric Food Chem; 2017 Nov; 65(47):10233-10242. PubMed ID: 29073354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
    Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
    Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A/IL-17 receptor signaling in a murine model.
    Al-Harbi NO; Nadeem A; Al-Harbi MM; Zoheir KMA; Ansari MA; El-Sherbeeny AM; Alanazi KM; Alotaibi MR; Ahmad SF
    Immunobiology; 2017 Feb; 222(2):128-136. PubMed ID: 27773660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
    van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
    J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T cells.
    Yoshiki R; Kabashima K; Honda T; Nakamizo S; Sawada Y; Sugita K; Yoshioka H; Ohmori S; Malissen B; Tokura Y; Nakamura M
    J Invest Dermatol; 2014 Jul; 134(7):1912-1921. PubMed ID: 24569709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
    Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
    Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.